독보적인 생명공학 기업, 에이프로젠
Primary TargetUndisclosed
PlatformBitargeting
Receptor-Antibody Hybrid
Indication퇴행성 관절염
Primary TargetCA12
PlatformBitargeting
Receptor-Antibody Hybrid
Indication삼중음성유방암
Primary TargetCD47
PlatformImmune Checkpoint Blocking Antibody
Indication림프종, 고형암
Primary TargetCD43
PlatformBispecific Antibody
Indication급성백혈병
Primary TargetTag72
PlatformBitargeting
Receptor-Antibody Hybrid
Indication대장암